iShares Trust - iShares Biotechnology ETF (IBB) Short Interest
Nasdaq • IBB • US4642875565
As of Nov 2, 2026, ORTEX estimates 21.8% of free float is sold short, 6.2 days to cover, cost to borrow 1.9%.
Nasdaq • IBB • US4642875565
As of Nov 2, 2026, ORTEX estimates 21.8% of free float is sold short, 6.2 days to cover, cost to borrow 1.9%.
This page tracks how heavily iShares Trust - iShares Biotechnology ETF (Nasdaq:IBB) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
iShares Trust - iShares Biotechnology ETF (Nasdaq: IBB) has a market capitalization of $11.39B. Last close $215.47 (as of 2026-11-04); 52-week range $154.63 to $222.29. ORTEX data as of 2026-11-02: short interest is 21.84% of free float, 6.2 days to cover and the average cost to borrow is 1.9%.